Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Inger S. Nijhof, Laurens E. Franssen, Mark-David Levin, Gerard M. J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Paula F. Ypma, Reinier Raymakers, Dick-Johan van Spronsen, Peter E. Westerweel, Rimke Oostvogels, Jeroen van Velzen, Berris van Kessel, Tuna Mutis, Pieter SonneveldSonja Zweegman, Henk M. Lokhorst, Niels W. C. J. van de Donk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2297-2306
JournalBlood
Volume128
Issue number19
DOIs
Publication statusPublished - 10 Nov 2016

Cite this